The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
delafloxacin meglumine · Injection, Powder, Lyophilized, For Solution
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 450 mg · Tablet · #1 bottle/carton / 20 tablet in 1 bottle · 450 mg · Tablet · #2 blister packs/carton / 10 tablet in 1 blister pack
Same drug class
Other molecules FDA puts in Fluoroquinolone Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- ciprofloxacin hcl· 1 maker
- ciprofloxacin hydrochloride and dexamethasone· 1 maker
- ciprofloxacin tablets· 2 makers
- moxifloxacin ophthalmic solution· 2 makers
- moxifloxacin hydrochloride tablets, 400 mg· 3 makers
- moxifloxacin ophthalmic· 3 makers
- ciprofloxacin hydrochloride and hydrocortisone· 4 makers
- ciprofloxacin and dexamethasone· 11 makers
- ciprofolxacin· 17 makers
- moxifloxacin· 19 makers
- moxifloxacin hydrochloride· 28 makers
- ciprofloxacin hydrochloride· 39 makers
Common questions
- Is Delafloxacin meglumine in shortage right now?
- No. FDA does not currently list Delafloxacin meglumine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Delafloxacin meglumine?
- 3 companies have marketed Delafloxacin meglumine in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.